RFL — Rafael Holdings, Inc.
—
NYSE ·
Health Care ·
Pharmaceuticals ·
CIK 1713863 ·
Last close
$1.94
Market Cap
$99.35M
52W High
$3.96
52W Low
$1.22
ADV30
225,540
Next earnings
2026-10-28
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Apr 2026 | 179,000 | 171,000 | -6,870,000 | -4,226,000 | 91,990,000 | 30,497,000 | 11,187,000 |
| Jan 2026 | 211,000 | 199,000 | -6,655,000 | -6,417,000 | 99,315,000 | 37,779,000 | 16,057,000 |
| Oct 2025 | 240,000 | 231,000 | -10,141,000 | -9,816,000 | 105,375,000 | 45,539,000 | 16,195,000 |
| Apr 2025 | 362,000 | 322,000 | -5,913,000 | -4,779,000 | 108,096,000 | 37,936,000 | 23,578,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-24,803,000
Investing CF
$-7,883,000
Financing CF
$-79,000
CapEx
$-23,000
Dividends Paid
—
Buybacks
$0
EPS Diluted TTM
$-0.59
As of
2026-06-14
Balance + Analyst (yfinance extras)
Retained Earnings
$-252,722,000
Inventory
$276,000
Receivables
$294,000
ST Investments
$0
EBIT TTM
$-24,928,000
Pretax Income TTM
$-25,420,000
Interest Exp TTM
$492,000
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$980,000
EBITDA
$-36,238,000
Free Cash Flow
$-20,674,000
Enterprise Value
$76,409,992
Total Cash
$30,497,000
Total Debt
$610,000
Shares Out
51,212,833
Trailing EPS
$-0.72
Book Value
$1.45
ROE
-37.6%
ROA
-22.8%
Div Yield
—
Annual Trend (SEC EDGAR, last 5y)
Revenues vs Net Income (last 5y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Jul 2025 | — | — | — | — | — | — | — |
| Jul 2024 | 637,000 | -102,627,000 | -34,410,000 | 96,832,000 | 10,574,000 | — | -7,802,000 |
| Jul 2023 | 279,000 | -15,043,000 | -1,876,000 | 98,829,000 | 2,200,000 | — | -10,886,000 |
| Jul 2022 | 410,000 | -60,477,000 | -124,658,000 | 118,320,000 | 21,114,000 | — | -26,079,000 |
| Jul 2021 | 802,000 | -21,199,000 | -24,544,000 | 154,055,000 | 17,351,000 | — | -15,601,000 |
Max Pain — expiry 2026-08-21
max pain strike: $2.50 · spot: $1.94 · call oi: 1,713 · put oi: 6,725
Expected Move to 2026-08-21:
±$1.18
(60.57%) —
implied range
$0.77 –
$3.12
· ATM straddle on $2.50 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| HSTC | HST Global, Inc. | $99.00M | $0.70 | — |
| CPIX | CUMBERLAND PHARMACEUTICALS INC | $100.09M | $6.68 | — |
| COYA | Coya Therapeutics, Inc. | $98.29M | $4.19 | — |
| RVRC | Revium Rx. | $101.42M | $1.67 | — |
| FBIO | Fortress Biotech, Inc. | $103.98M | $3.13 | — |
News headlines (Yahoo Finance, 1h cache)
Israel said to eye US listing for major defense firms
2026-06-23 16:10 · Yahoo
Rafael Holdings Reports Third Quarter Fiscal 2026 Financial Results
2026-06-11 11:30 · Yahoo
Rafael Holdings Announces Completion of Last Patient Last Visit for Pivotal Phase 3 TransportNPC™ Study Evaluating Trappsol® Cyclo™ for the Treatment of Niemann-Pick Disease Type C
2026-06-10 11:30 · Yahoo
Rafael Holdings Insider Ups Holding By 1,810% During Year
2026-04-28 14:26 · Yahoo
Rafael Holdings Announces Patent Licensing Agreement with MIT for “Small Molecules to Improve Myelination in ApoE4 positive Alzheimer’s Disease”
2026-04-22 11:00 · Yahoo
Rafael Holdings Reports Second Quarter Fiscal 2026 Financial Results
2026-03-16 20:01 · Yahoo
Rafael Holdings Reports First Quarter Fiscal 2026 Financial Results
2025-12-11 21:01 · Yahoo
One Rafael Holdings Insider Raised Stake By 1,810% In Previous Year
2025-11-19 13:58 · Yahoo
Rafael Holdings Reports Fourth Quarter and Full Year Fiscal 2025 Financial Results
2025-10-29 20:24 · Yahoo
Rafael Holdings Mourns the Passing of Lead Independent Director, Stephen Greenberg, and Announces the Appointment of Alan Grayson to its Board of Directors
2025-10-28 20:01 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.